BioCentury | May 30, 2011
Company News
Specifar Pharmaceuticals S.A., Watson deal
...AstraZeneca plc (LSE:AZN; NYSE:AZN, London, U.K.) markets Nexium esomeprazole to treat gastroesophageal reflux disease (GERD). Specifar Pharmaceuticals S.A....
Products & Solutions
About Biocentury
Contact
Privacy & Legal
- Follow Us
